| Application no. and date | 14815149.1 (espacenet) (Federated) (European Patent Register), 20141121 | | Patent/reg. no. and date | DK/EP 3071206, 20210217 | | Publication date | 20160928 | | Priority no. and date | US 201361907980 P, 20131122 | | EP pub. no. and date |
EP 3071206 20160928 | | Effective date | | | Applicant/owner | CL Biosciences LLC, Hunkens Waterfront Plaza
Hunkens Waterfront PlazaMain Street
P.O. Box 556
Charlestown, KN | | Applicant ref. no. | 1595599 | | Inventor | MODLIN, Irvin Mark, 11 Tulip Tree Lane
Woodbridge, Connecticut 06525, US,
KIDD, Mark, 1a Ira Street
New Haven, Connecticut 06512, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/5513 (2006.01) , A61P 1/04 (2006.01) , A61P 19/10 (2006.01) | | Title | GASTRINANTAGONISTER (EG YF476, NETAZEPID) TIL BEHANDLING OG FOREBYGGELSE AF OSTEOPOROSE | | Int. application no. | US2014066832 | | Int. publication no. | WO2015077572 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
